<DOC>
	<DOCNO>NCT01188369</DOCNO>
	<brief_summary>This clinical , randomised , double-blinded study patient eligible aortic valve replacement enrol . Patients receive infusion either levosimendan placebo 4 hour prior surgery end surgery .</brief_summary>
	<brief_title>Effects Levosimendan Patients Eligible Aortic Valve Replacement With Left Ventricular Hypertrophy</brief_title>
	<detailed_description>Levosimendan placebo infusion approximately 4 hour prior aortic valve replacement patient severe hypertrophy leave ventricle echocardiographic sign diastolic dysfunction . Outcome measure obtain follow : - Approximately 4 hour prior surgery . Baseline . Start levosimendan/placebo infusion - Immediately surgery - After induction anaesthesia `` knife time '' = start surgery . - At end surgery : Levosimendan infusion stop . - Approximately 4 hour surgery immediately extubation . - Approximately 21 hour surgery - Approximately 96 hour surgery ( day 4 ) - 6 month surgery Outcome measure comprise invasive measurement , blood sample , transthoracic echocardiography transoesophageal echocardiography focus measure systolic diastolic function heart . Interim analysis conduct 30 included patient .</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>Eligible aortic valve replacement EF &gt; 45 % Left ventricular posterior wall &gt; 12mm Sinus rhythm Concomitant bypass operation Severe mitral insufficiency Active endocarditis Insufficient ultrasound opportunity Systolic blood pressure &lt; 100 mmHg moderatesevere renal failure allergy levosimendan lack patient consent Pregnancy status lactate Fertile woman use relevant anticonception</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>levosimendan</keyword>
	<keyword>heart failure</keyword>
	<keyword>inotropics</keyword>
	<keyword>diastolic dysfunction</keyword>
	<keyword>leave ventricular hypertrophy</keyword>
	<keyword>aortic valve stenosis</keyword>
</DOC>